Study on preoperative low dose amiodarone administration for prevention of atrial fibrillation after off-pump coronary artery bypass grafting
10.3760/cma.j.issn.0254-9026.2009.06.005
- VernacularTitle:术前低剂量胺碘酮预防非体外循环冠状动脉旁路移植术后心房颤动
- Author:
Ying FANG
;
Zhao-guang ZHANG
;
Cheng-xiong GU
;
Yang YU
;
- Publication Type:Journal Article
- Keywords:
Coronary artery bypass off-pump;
Atrial fibrillation;
Anti-arrhythmia agents;
Amiodarone
- From:
Chinese Journal of Geriatrics
2009;28(6):457-459
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the safety, tolerability and efficacy of preoperative low dose intravenous amiodarone in the prevention of atrial fibrillation (AF) after off-pump coronary artery bypass grafting (OPCAB). Methods Two hundred patients with coronary atheroselerotic heart disease underwent selected OPCAB and were randomly divided into two groups: control group (100 cases) and experimental group (100 cases). Patients in control group were given conventional medicines and placebo, and patients in experimental group were treated with low dose intravenous amiodarone daily for 4 days before surgery. They were given conventional medicines after surgery. Results After the off-pump coronary artery bypass grafting, the incidence of AF, ventricular rate and the duration of AF in the experimental group were lower than those in control group [15% vs. 41%, χ2=16.766, P=0.000; (126.0±20.8) times/ min vs. (150.0±25.6) times/ min, t=0.478, P =0. 017; (8. 0±8. 6) h vs. (12.0±9.6) h, t=0. 439, P=0. 019]. No significant difference were found in the incidence of side effect between low close amiodarone group and the control group. Conclusions Prophylactic application of low dose intravenous arniodarone before off-pump coronary artery bypass grafting can safely and effectively reduce the postoperative ventricular rate and the incidence of AF, shorten the duration of AF, promote the rehabilitation and slightly improve the clinical symptoms.
